TY - CHAP
T1 - The complex biology of human cytomegalovirus latency
AU - Goodrum, Felicia
N1 - Funding Information:
I am grateful for critical feedback on the text from Dr. Luwanika Mlera, Pierce Longmire and Melissa Moy. F.G. and some of the work cited is supported by grants from the NIH AI079059, AI127335, and AI143191. All figures were created by BioRender.com .
Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022/1
Y1 - 2022/1
N2 - While many viral infections are limited and eventually resolved by the host immune response or by death of the host, other viruses establish long-term relationships with the host by way of a persistent infection, that range from chronic viruses that may be eventually cleared to those that establish life-long persistent or latent infection. Viruses infecting hosts from bacteria to humans establish quiescent infections that must be reactivated to produce progeny. For mammalian viruses, most notably herpesviruses, this quiescent maintenance of viral genomes in the absence of virus replication is referred to as latency. The latent strategy allows the virus to persist quiescently within a single host until conditions indicate a need to reactivate to reach a new host or, to re-seed a reservoir within the host. Here, I review common themes in viral strategies to regulate the latent cycle and reactivate from it ranging from bacteriophage to herpesviruses with a focus on human cytomegalovirus (HCMV). Themes central to herpesvirus latency include, epigenetic repression of viral gene expression and mechanisms to regulate host signaling and survival. Critical to the success of a latent program are mechanisms by which the virus can “sense” fluctuations in host biology (within the host) or environment (outside the host) and make appropriate “decisions” to maintain latency or re-initiate the replicative program. The signals or environments that indicate the establishment of a latent state, the very nature of the latent state, as well as the signals driving reactivation have been topics of intense study from bacteriophage to human viruses, as these questions encompass the height of complexity in virus-host interactions—where the host and the virus coexist.
AB - While many viral infections are limited and eventually resolved by the host immune response or by death of the host, other viruses establish long-term relationships with the host by way of a persistent infection, that range from chronic viruses that may be eventually cleared to those that establish life-long persistent or latent infection. Viruses infecting hosts from bacteria to humans establish quiescent infections that must be reactivated to produce progeny. For mammalian viruses, most notably herpesviruses, this quiescent maintenance of viral genomes in the absence of virus replication is referred to as latency. The latent strategy allows the virus to persist quiescently within a single host until conditions indicate a need to reactivate to reach a new host or, to re-seed a reservoir within the host. Here, I review common themes in viral strategies to regulate the latent cycle and reactivate from it ranging from bacteriophage to herpesviruses with a focus on human cytomegalovirus (HCMV). Themes central to herpesvirus latency include, epigenetic repression of viral gene expression and mechanisms to regulate host signaling and survival. Critical to the success of a latent program are mechanisms by which the virus can “sense” fluctuations in host biology (within the host) or environment (outside the host) and make appropriate “decisions” to maintain latency or re-initiate the replicative program. The signals or environments that indicate the establishment of a latent state, the very nature of the latent state, as well as the signals driving reactivation have been topics of intense study from bacteriophage to human viruses, as these questions encompass the height of complexity in virus-host interactions—where the host and the virus coexist.
KW - Herpesvirus cytomegalovirus latency reactivation
UR - http://www.scopus.com/inward/record.url?scp=85126748135&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126748135&partnerID=8YFLogxK
U2 - 10.1016/bs.aivir.2022.01.001
DO - 10.1016/bs.aivir.2022.01.001
M3 - Chapter
C2 - 35840181
AN - SCOPUS:85126748135
SN - 9780323989909
T3 - Advances in Virus Research
SP - 31
EP - 85
BT - Advances in Virus Research
A2 - Kielian, Margaret
A2 - Mettenleiter, Thomas C.
A2 - Roossinck, Marilyn J.
PB - Academic Press Inc.
ER -